Company: MVIS
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000783
Chunk: 107

Company: MICROVISION, INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 1B
Chunk 107
---
. During the year ended December 31, 2024, we made payments totaling $6.3 million related
to the acquisition of Ibeo assets compared to $11.2 million in the same period in 2023.

28

Financing
activities

Net
cash provided by financing activities totaled $72.9 million during the year ended December 31, 2024, compared to $72.4 million during
the same period of 2023. Proceeds received from stock option exercises totaled $0.1 million during the year ended December 31, 2024,
compared to $0.3 million during the same period in 2023. Net proceeds from issuance of common stock were $34.7 million during the year
ended December 31, 2024, compared to $72.3 million during the same period in 2023. In 2024, we received approximately $38.1 million in
net proceeds, inclusive of debt issuance costs, from the issuance of $45.0 million senior secured convertible notes. See Part II,
Item 8. Note 7, Notes Payable and Derivative Liabilities.

The
following is a list of our financing activities during 2024 and 2023.

    ●
    In
    October 2024, we entered into a Securities Purchase Agreement (the “Purchase Agreement”) for the purchase of senior secured
    convertible notes (the “Note”) with an institutional investor (the “Holder”). The principal amount for the
    initial note is $45.0 million, with an option for the Company to issue additional principal in the amount of $30.0 million of convertible
    notes to the Holder, subject to certain limitation. We received proceeds, net of all costs, of $38.1 million. 

    ●
    In
    March 2024, we entered into a $150.0 million ATM equity offering agreement with Deutsche Bank Securities, Inc., Mizuho Securities
    USA LLC and Craig-Hallum Capital Group LLC (collectively, the “Agents”). Under the agreement, we are able, at our discretion,
    to offer and sell shares of our common stock having an aggregate value of up to $150.0 million through or directly to the Agents.
    As of December 2024, we completed sales under such sales agreement of 23.3 million shares for net proceeds of $34.7 million. As of
    December 31,